ZyVersa Therapeutics Stock (NASDAQ: ZVSA) stock price, news, charts, stock research, profile.
Open | $3.63 |
Close | $3.76 |
Volume / Avg. | 37.33K / 204.09K |
Day Range | 3.50 - 3.76 |
52 Wk Range | 3.41 - 230.30 |
Market Cap | $3.06M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 4.2% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ZyVersa Therapeutics (NASDAQ:ZVSA) through any online brokerage.
Other companies in ZyVersa Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
There is no analysis for ZyVersa Therapeutics.
ZyVersa Therapeutics has a consensus price target of $12.00.
The stock price for ZyVersa Therapeutics (NASDAQ: ZVSA) is $3.6613 last updated June 28, 2024 at 4:51 PM EDT.
There are no upcoming dividends for ZyVersa Therapeutics.
ZyVersa Therapeutics’s Q2 earnings are confirmed for Monday, August 19, 2024.
There is no upcoming split for ZyVersa Therapeutics.
ZyVersa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.